Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Oxidative stress promotes fibrosis in systemic sclerosis through stabilization of a kinase-phosphatase complex
Ruiyuan Zhang, … , Wolfgang Peti, Nunzio Bottini
Ruiyuan Zhang, … , Wolfgang Peti, Nunzio Bottini
Published April 22, 2022
Citation Information: JCI Insight. 2022;7(8):e155761. https://doi.org/10.1172/jci.insight.155761.
View: Text | PDF
Research Article Inflammation

Oxidative stress promotes fibrosis in systemic sclerosis through stabilization of a kinase-phosphatase complex

  • Text
  • PDF
Abstract

Systemic sclerosis (SSc) is a fibrotic autoimmune disease characterized by pathogenic activation of fibroblasts enhanced by local oxidative stress. The tyrosine phosphatase PTP4A1 was identified as a critical promoter of TGF-β signaling in SSc. Oxidative stress is known to functionally inactivate tyrosine phosphatases. Here, we assessed whether oxidation of PTP4A1 modulates its profibrotic action and found that PTP4A1 forms a complex with the kinase SRC in scleroderma fibroblasts, but surprisingly, oxidative stress enhanced rather than reduced PTP4A1’s association with SRC and its profibrotic action. Through structural assessment of the oxo-PTP4A1-SRC complex, we unraveled an unexpected mechanism whereby oxidation of a tyrosine phosphatase promotes its function through modification of its protein complex. Considering the importance of oxidative stress in the pathogenesis of SSc and fibrosis, our findings suggest routes for leveraging PTP4A1 oxidation as a potential strategy for developing antifibrotic agents.

Authors

Ruiyuan Zhang, Ganesan Senthil Kumar, Uwe Hansen, Martina Zoccheddu, Cristiano Sacchetti, Zachary J. Holmes, Megan C. Lee, Denise Beckmann, Yutao Wen, Zbigniew Mikulski, Shen Yang, Eugenio Santelli, Rebecca Page, Francesco Boin, Wolfgang Peti, Nunzio Bottini

×

Figure 3

PTP4A1 binds SRC on the SH3SH2 domains.

Options: View larger image (or click on image) Download as PowerPoint
PTP4A1 binds SRC on the SH3SH2 domains.
(A and B) Representative Western...
(A and B) Representative Western blotting (left) with quantification (right) of (A) binding of purified full-length SRC to Ni-NTA agarose-bound His6-tagged PTP4A1 with Ni-NTA beads as control (n = 5) and (B) binding of GST-tagged SRC SH3SH2 to Ni-NTA agarose-bound His6-tagged PTP4A1 (n = 5). (C) SPR sensorgram (red) of oxidized PTP4A1 binding to immobilized His6-tagged SRC SH3SH2 with fit to a 1:1 kinetic model (black) and residuals plot (Δ). Two-tailed paired t test in A and B. ***P < 0.001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts